Australian Market Notably Higher

RTTNews | 32 hari yang lalu
Australian Market Notably Higher

(RTTNews) - The Australian stock market is currently trading notably higher on Monday, recouping some of the losses in the previous four sessions, with the benchmark S&P/ASX 200 moving to near the 7,800.00 level, following the broadly positive cues from Wall Street on Friday, with gains across most sectore led by gold miners, technology and financial stocks.

The benchmark S&P/ASX 200 Index is gaining 44.80 points or 0.58 percent to 7,772.40, after touching a high of 7,780.20 earlier. The broader All Ordinaries Index is up 43.10 points or 0.54 percent to 8,042.30. Australian stocks closed sharply lower on Friday.

Among the major miners, Rio Tinto, Mineral Resources and Fortescue Metals are edging down 0.1 to 0.5 percent each, while BHP Group is edging up 0.5 percent. Oil stocks are mostly higher. Beach energy and Origin Energy are gaining almost 1 percent each, while Santos is edging up 0.5 percent. Woodside Energy is edging down 0.4 percent.

Among tech stocks, Xero and Appen are gaining almost 1 percent each, while Afterpay owner Block and WiseTech Global ares edging up 0.1 to 0.2 percent each. Zip is advancing more than 3 percent.

Gold miners are higher. Resolute Mining and Newmont are up almost 1 percent each, while Northern Star Resources and Evolution Mining are adding almost 2 percent each. Gold Road Resources is gaining more than 2 percent.

Among the big four banks, Commonwealth Bank is gaining more than 1 percent, while ANZ Banking, Westpac and National Australia Bank are adding almost 1 percent each.

In other news, shares in Lendlease are surging almost 9 percent after it unveiled sweeping changes to its global strategy.

Shares in Vista Group are soaring 19 percent after private capital firm Potentia Group acquired an 18.5 percent stake in the film software company.

In the currency market, the Aussie dollar is trading at $0.663 on Monday.

On Wall Street, stocks showed a strong move back to the upside during trading on Friday following the downturn seen over the course of the previous session. The tech-heavy Nasdaq led the rebound, surging to a new record closing high.

The Nasdaq jumped 184.76 points or 1.1 percent to 16,920.94 and the S&P 500 climbed 36.88 points or 0.7 percent to 5,304.72, while the narrower Dow ended the day roughly flat, inching up just 4.33 points or less than a tenth of a percent to 39,069.59.

Meanwhile, the major European markets also moved to the downside on the day. The U.K.'s FTSE 100 Index dipped by 0.3 percent and the French CAC 40 Index edged down by 0.1 percent, although the German DAX Index closed just above the unchanged line.

Crude oil prices moved higher Friday, snapping a four-day losing streak despite concerns about the outlook for demand. West Texas Intermediate crude oil futures for July ended higher by $0.85 at $77.72 a barrel.

read more
Moderna Says CHMP Recommends Marketing Authorization For MRESVIA RSV Vaccine In EU

Moderna Says CHMP Recommends Marketing Authorization For MRESVIA RSV Vaccine In EU

Moderna, Inc. (MRNA) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of marketing authorization in the European Union for mRESVIA (mRNA-1345) to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection.
RTTNews | 4j 23min yang lalu
Bay Street Likely To Open On Positive Note

Bay Street Likely To Open On Positive Note

Higher commodity prices and fairly steady European markets point to a positive start for Canadian stocks Friday morning. The focus will be on U.S. Personal Consumption Expenditure (PCE) data, as the Fed's preferred inflation gauge is expected to provide clues about the outlook for interest rates.
RTTNews | 4j 41min yang lalu
Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of odronextamab to treat adults with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.
RTTNews | 5j 25min yang lalu
U.S. Dollar Firms Ahead Of U.S. Core PCE Inflation Data

U.S. Dollar Firms Ahead Of U.S. Core PCE Inflation Data

The U.S. dollar strengthened against other major currencies in the early European session on Friday, as traders eagerly await the release of closely watched U.S. inflation data later in the day that may shed additional clues on the interest-rate outlook.
RTTNews | 7j 1min yang lalu
FTSE 100 Rises As Q1 GDP Grows Faster Than Expected

FTSE 100 Rises As Q1 GDP Grows Faster Than Expected

U.K. stocks were moving higher on Friday as investors reacted to stronger-than-expected U.K. GDP figures and awaited a key U.S. inflation reading later in the day for clues on when interest rates may be cut.
RTTNews | 7j 36min yang lalu